CJC-1295 Peptide Buyer's Guide: What Researchers Need (2026)

If you're a qualified researcher sourcing CJC-1295 peptide for endocrine, metabolic, or peptide-signalling studies, the quality of your starting material shapes every result downstream. This guide covers the key decisions: DAC versus no-DAC variants, what a credible Certificate of Analysis looks like, and which quality markers actually matter when comparing suppliers. PeptideValidation.com supplies CJC-1295 as a 5 mg lyophilized powder, formulated specifically for controlled laboratory research into growth-hormone-releasing pathways. For research use only. Not for human or veterinary use.

What Is CJC-1295 Peptide?

CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH) consisting of 30 amino acids. It is used in laboratory research to study growth-hormone-releasing pathways and peptide signalling. A DAC (Drug Affinity Complex) variant extends plasma half-life significantly, making the two forms functionally distinct for experimental design.

CJC-1295 was first synthesised to address the short biological half-life of native GHRH. In its standard form, the peptide degrades quickly under physiological conditions, which limits its utility in certain study designs. The DAC modification changes that.

The DAC variant binds to albumin in plasma, extending the half-life from minutes to several days. That distinction matters for researchers designing experiments around pulsatile versus sustained GH-release models. Choosing the wrong variant skews your data before the experiment even starts.

For laboratory purposes, CJC-1295 is not a steroid. It belongs to the peptide class, acting on GHRH receptors rather than androgen or oestrogen pathways. Researchers sometimes ask "is CJC-1295 a steroid?" because of how it is discussed online. The answer is clearly no: it is a peptide hormone analogue with a distinct mechanism from anabolic steroids.

At PeptideValidation.com, the compound is supplied as a 5 mg lyophilized powder. Lyophilization (freeze-drying) preserves peptide integrity during storage and shipping, reducing the degradation risk that affects liquid preparations. Each batch is intended for use by qualified researchers in controlled laboratory settings.

CJC-1295 with DAC vs. Without DAC: Which Do You Need?

CJC-1295 without DAC has a half-life of roughly 30 minutes. CJC-1295 with DAC extends this to approximately 6 to 8 days by binding albumin. Choose the standard form for pulsatile GH-release models and the DAC form for sustained-release experimental protocols.

The DAC modification is not cosmetic. It changes the pharmacokinetic profile enough that researchers treating the two compounds as interchangeable will get inconsistent results. Here is a practical breakdown:

CJC-1295 (no DAC)

• Half-life: approximately 30 minutes
• Release pattern: mirrors natural pulsatile GH secretion
• Best for: studies examining discrete GH pulses or receptor sensitivity windows

CJC-1295 with DAC

• Half-life: approximately 6 to 8 days
• Release pattern: sustained, relatively flat GH elevation
• Best for: studies that require prolonged GHRH receptor activation or that track downstream IGF-1 responses over days

When reviewing CJC-1295 with DAC dosage parameters in published literature, you will typically see molar quantities adjusted to account for the extended activity window. That adjustment is an experimental design choice, not a standard dosage prescription. Always anchor your protocol to peer-reviewed studies relevant to your specific research model.

One practical note: because the DAC form has a much longer window of activity, error correction during an experiment is harder. If something goes wrong with a treatment arm, you cannot simply stop the compound's effect the same day. That is a genuine trade-off researchers should factor into their study designs before sourcing.

CJC-1295 Peptide Quality: What to Check Before You Order

Before sourcing CJC-1295 peptide, verify five things: HPLC purity at 98% or higher, mass spectrometry identity confirmation, a batch-specific COA from an independent third-party lab, documented storage conditions, and the supplier's quality management system. Any supplier unable to provide all five warrants caution.

Quality verification is not optional when research reproducibility is on the line. A peptide with 85% purity introduces unknowns that a 99% pure compound does not. The 15% difference could be inactive truncation products, solvent residues, or uncharacterised by-products, any of which can confound downstream assays.

Five things to confirm before you place an order:

1. HPLC purity: Look for 98% or higher as a baseline for research-grade material. Some vendors list purity without specifying the method. HPLC is the standard; UV absorbance alone is not sufficient.
2. Mass spectrometry (MS) identity: Confirms the compound's molecular weight matches theoretical values for CJC-1295. This rules out substitution errors.
3. Batch-specific COA: Generic COAs covering multiple lots are a red flag. Each batch should have its own documentation, tied to a specific lot number.
4. Third-party testing: In-house testing only is a conflict of interest. Independent lab verification adds a meaningful layer of accountability.
5. Storage and stability data: CJC-1295 lyophilized powder is generally stable at -20 degrees Celsius when kept dry. Suppliers should specify recommended storage conditions on the COA.

PeptideValidation.com's certification criteria for vendors include all five of these elements, along with transparent sourcing practices and responsive technical support. The goal is straightforward: researchers should not have to guess whether their compound is what the label says it is.

CJC-1295 Peptide in Research: What the Studies Explore

Research into CJC-1295 peptide benefits focuses on its ability to stimulate GH secretion via GHRH receptors, study downstream IGF-1 responses, and model sustained versus pulsatile endocrine signalling. These are laboratory-based findings. No approved therapeutic use exists as of 2026.

The research interest in CJC-1295 centres on its interaction with the somatotropic axis. GHRH receptors on somatotroph cells in the pituitary respond to the peptide by triggering GH release. Downstream, that GH signal prompts hepatic IGF-1 production. The cascade is well-characterised in rodent models and has informed endocrine research broadly.

Studies examining CJC-1295 peptide benefits in laboratory settings have looked at several areas:

• GH pulse amplitude and frequency: How does GHRH analogue concentration affect the size and spacing of GH pulses?
• IGF-1 kinetics: What is the time course of hepatic IGF-1 response following a single or repeated GHRH stimulus?
• Metabolic signalling interactions: How does sustained GH elevation influence lipid mobilisation or protein synthesis markers in cell-based assays?
• DAC pharmacokinetics: How does albumin binding affect tissue exposure and receptor occupancy over time?

These are research questions, not clinical claims. CJC-1295 has no approved human therapeutic indication as of August 2026. Its value to the scientific community lies entirely in what it reveals about peptide signalling mechanisms under controlled conditions.

For metabolic and endocrine research teams, that mechanistic clarity is the point. A well-characterised GHRH analogue with a predictable half-life gives experimenters a reliable tool for probing the somatotropic axis without the variability of native GHRH.

CJC-1295 Peptide Price and What It Signals About Quality

CJC-1295 peptide price varies widely between suppliers. Significant underpricing (below $30 per 5 mg) often correlates with lower purity, absent third-party testing, or no batch-specific COA. Research-grade material costs more because independent analytical verification costs more to produce.

Price is not the only quality signal, but it is a useful filter. Synthesising a 30-amino-acid peptide to 98%+ purity, running HPLC and MS confirmation, commissioning independent third-party testing, and maintaining a documented quality management system all add cost. Suppliers who skip those steps can price lower. That is not a coincidence.

When comparing CJC-1295 peptide price across vendors, look past the per-vial number and ask:

• What does the listed purity represent, and which method was used to measure it?
• Is the COA batch-specific or generic?
• Who ran the third-party testing, and can you see the lab report?
• What is the stated shelf life and storage recommendation?

A 5 mg vial of research-grade lyophilized CJC-1295 from a vendor with genuine third-party certification will reflect those costs. Paying less than that might feel like a bargain until an experiment fails to replicate because the compound was not what the label claimed.

For researchers managing lab budgets, the calculus is simple: the cost of a compromised compound is not just the purchase price. It is the time, consumables, and personnel hours spent on experiments built on unreliable starting material. Quality is an economic argument, not just a scientific one.

How to Read a CJC-1295 Certificate of Analysis

A valid CJC-1295 Certificate of Analysis includes: peptide identity via mass spectrometry, HPLC purity percentage and method, molecular weight, batch and lot number, manufacturing date, recommended storage conditions, and the name of the testing laboratory. Missing any of these items is a warning sign.

The COA is the single most important document a researcher can request before incorporating a peptide into a study. Reading one correctly takes about three minutes. Here is what each section should tell you.

Identity confirmation: The MS result should match the theoretical molecular weight of CJC-1295. For the no-DAC form, the expected average molecular weight is approximately 3367 Da. The DAC form differs because of the maleimido-propionic acid modification. If the supplier's COA does not show MS data, ask for it separately.

HPLC purity: This number should appear as a percentage with a corresponding chromatogram or at least a reference to one. "Purity: 99.2% by HPLC" is informative. "High purity" is not.

Batch and lot number: Cross-reference this against the vial label. They should match exactly. Mismatches suggest poor inventory controls.

Testing laboratory: An independent lab name and, ideally, an accreditation reference (ISO 17025 is the relevant standard for analytical testing labs) adds accountability. In-house testing alone is insufficient for research-grade claims.

Storage and expiry: CJC-1295 lyophilized powder is generally stored at -20 degrees Celsius, protected from light and moisture. The COA should state this explicitly. If it does not, ask before you store the compound incorrectly and degrade it before use.

PeptideValidation.com's vendor certification process checks all of these elements as baseline criteria, so researchers can assess suppliers against a consistent standard rather than guessing.

Sourcing CJC-1295 Peptide: A Pre-Purchase Checklist for Researchers

Before sourcing CJC-1295 peptide for laboratory research, confirm: (1) batch-specific COA with HPLC and MS data, (2) independent third-party testing, (3) lyophilized powder format for stability, (4) correct variant (DAC or no DAC) for your protocol, and (5) vendor transparency on sourcing and quality management.

Pulling together everything covered in this guide, here is a practical pre-purchase checklist for research teams considering CJC-1295 peptide buy decisions.

Before you order:

• Confirm the variant you need: CJC-1295 no DAC for pulsatile models, CJC-1295 DAC for sustained-release protocols.
• Request a batch-specific COA and verify it includes HPLC purity (98%+), MS identity, lot number, storage requirements, and testing lab name.
• Check whether third-party independent testing was performed, not just in-house QC.
• Verify the physical format: lyophilized powder is preferred over pre-reconstituted liquid for stability during shipping and storage.
• Confirm the supplier's documentation practices, including how they handle batch failures or quality deviations.

During and after receipt:

• Cross-reference the vial label lot number against the COA immediately on receipt.
• Store at -20 degrees Celsius in a dry, dark environment unless the COA specifies otherwise.
• Document the receipt date and lot number in your lab records for traceability.

For a deeper look at the full research landscape around this compound, including mechanism of action, receptor biology, and experimental context, the complete research guide is worth reading before finalising your protocol. Good sourcing decisions start with good background knowledge, and both are necessary for reproducible results.

Frequently asked questions

What is CJC-1295 peptide used for in research?

CJC-1295 peptide is used in laboratory research to study growth-hormone-releasing hormone (GHRH) receptor activation, GH secretion patterns, downstream IGF-1 responses, and peptide signalling within the somatotropic axis. It is not approved for human or veterinary therapeutic use as of 2026.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 without DAC has a half-life of roughly 30 minutes and produces pulsatile GH release, which mirrors natural GHRH activity. CJC-1295 with DAC binds albumin in plasma, extending the half-life to approximately 6 to 8 days and creating a sustained GH-release profile. The choice between them depends on your experimental design.

Is CJC-1295 a steroid?

No. CJC-1295 is a synthetic peptide analogue of growth-hormone-releasing hormone, not a steroid. It acts on GHRH receptors in the pituitary rather than on androgen or oestrogen pathways. The two compound classes have distinct chemical structures and distinct mechanisms of action.

What should I look for in a CJC-1295 Certificate of Analysis?

A credible CJC-1295 COA should include: peptide identity confirmed by mass spectrometry, HPLC purity at 98% or higher, molecular weight, a batch-specific lot number, manufacturing date, recommended storage conditions (typically -20 degrees Celsius), and the name of the independent testing laboratory. Generic COAs not tied to a specific batch are a red flag.

What does CJC-1295 with DAC dosage look like in published research?

Published laboratory studies on CJC-1295 with DAC dosage vary widely depending on the animal model, endpoint being measured, and study duration. Because the DAC form has a half-life of approximately 6 to 8 days, molar quantities used are typically adjusted to reflect the extended activity window. Researchers should anchor protocols to peer-reviewed literature relevant to their specific model rather than generalised dosage figures.

Why does CJC-1295 peptide price vary so much between suppliers?

Price variation in CJC-1295 peptide reflects differences in synthesis quality, purity testing methods, and whether independent third-party lab verification is included. Research-grade material synthesised to 98%+ purity with HPLC and MS confirmation and independent COA testing costs more to produce. Significant underpricing often signals that one or more of these quality steps has been skipped.

Related in this series

• CJC-1295 Peptide Buyer's Guide: What Researchers Need (2026)